Britton, K. E. (1998). Highlights lecture of the European Association of Nuclear Medicine and the World Federation of Nuclear Medicine and Biology Congress, Berlin 1998. Where next and how?.
Abstract: Nuclear medicine benefits not only the people of developed countries but also those who are in developing or deteriorating countries. The combination of diagnostic imaging, tissue characterisation, function measurement and targeted therapy is powerful and cost-effective. This congress provides a sample of nuclear medicines contribution to the world.
Keywords: Humans; Neoplasms/radionuclide imaging/radiotherapy; *Nuclear Medicine; 2013
Notes: Pmid:9871100
|
Britton, K. E. (1998). Highlights lecture of the European Association of Nuclear Medicine and the World Federation of Nuclear Medicine and Biology Congress, Berlin 1998. Where next and how?.
Abstract: Nuclear medicine benefits not only the people of developed countries but also those who are in developing or deteriorating countries. The combination of diagnostic imaging, tissue characterisation, function measurement and targeted therapy is powerful and cost-effective. This congress provides a sample of nuclear medicines contribution to the world.
Keywords: Humans; Neoplasms/radionuclide imaging/radiotherapy; *Nuclear Medicine; 2013
Notes: Pmid:9871100
|
Durr-e-Sabih,. (1997). Nuclear medicine in the Third World: which way to go? Nuclear Medicine Communications, 18(5), 393–394.
Keywords: Developing Countries; Humans; Nuclear Medicine/economics/*trends; 2013
Notes: Pmid:9194078
|
Durr-e-Sabih,. (1997). Nuclear medicine in the Third World: which way to go? Nuclear Medicine Communications, 18(5), 393–394.
Keywords: Developing Countries; Humans; Nuclear Medicine/economics/*trends; 2013
Notes: Pmid:9194078
|
Durr-e-Sabih,. (1997). Nuclear medicine in the Third World: which way to go? Nuclear Medicine Communications, 18(5), 393–394.
Keywords: Developing Countries; Humans; Nuclear Medicine/economics/*trends; 2013
Notes: Pmid:9194078
|
